NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Fibrosis



Resolution Recognizing IPF and CPF's National IPF Awareness Week Passes Senate



August 18th, 2007

The Coalition for Pulmonary Fibrosis (CPF) announced the passage of important legislation that recognizes the need for research into the cause of idiopathic pulmonary fibrosis (IPF), a deadly lung disease with no known cause, no FDA-approved treatment, or cure. Senate Concurrent Resolution 42 (S. Con. Res. 42) recognizes the CPF's National IPF Awareness Week and raises the importance of the urgent need to identify viable treatments and an eventual cure for IPF, a disease that is becoming alarmingly more prevalent in the United States.

"The passage of this resolution in the Senate demonstrates that support is growing for the thousands of Americans who are fighting IPF,"...


Source: Law & Health Weekly (2007-08-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login